Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06506565

Low-Dose Ketamine Infusion During Burn Wound Care

A Randomized, Placebo-Controlled, Double-Blind Evaluation of Low-Dose Ketamine Infusion During Burn Wound Care Procedures to Improve Pain Intensity and Reduce Opioid Consumption

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
140 (estimated)
Sponsor
University of Tennessee · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The current standard of care (SOC) (i.e. fentanyl and midazolam) offers limited efficacy for preventing or relieving pain. Ketamine infusions may provide the benefits of analgesia, minimize adverse events, and reduce opioid use. The purpose of this study is to determine if adding a low dose ketamine infusion during wound care will safely provide pain relief for patients with burn injury.

Conditions

Interventions

TypeNameDescription
DRUGKetamineInfusion during wound care
DRUG0.9% NaClInfusion during wound care

Timeline

Start date
2024-07-08
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2024-07-17
Last updated
2024-12-13

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06506565. Inclusion in this directory is not an endorsement.